Stay updated with breaking news from Marks George. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intermittent theta burst stimulation for refractory depression failed to outperform rTMS. Nevertheless, the results are valuable because they show the potential merit of an individualized approach.
It is time for the mental health industry to embrace modern and advanced technology to help treatment-resistant patients.
/PRNewswire/ -- MAPS Public Benefit Corporation ("MAPS PBC"), a private biopharmaceutical company dedicated to the development and commercialization of...
MAPS PBC Announces Frontiers in Psychiatry Published First Study to Evaluate Neural Impact of MDMA-Assisted Therapy in Patients with PTSD - read this article along with other careers information, tips and advice on BioSpace
The FDA has cleared the SAINT Neuromodulation System for the treatment of MDD in adults who have failed prior antidepressant medications.